Back to results
US 5,998,206 AGranted
Antisense inhibiton of human G-alpha-12 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorLex M. Cowsert
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of G-alpha-12. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding G-alpha-12. Methods of using these compounds for modulation of G-alpha-12 expression and for treatment of diseases associated with expression of G-alpha-12 are provided.
Claims10
An antisense compound 8 to 30 nucleotides in length targeted to a nucleic acid molecule encoding human G-alpha-12, wherein said antisense compound inhibits the expression of human G-alpha-12.
Dependencies are inferred from the claim text.